Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013.

Background: There are limited large case series of peristomal pyoderma gangrenosum (PPG), an uncommon cause of recalcitrant peristomal ulceration.Objective: We sought to further characterize the clinical features, causes, treatments, and outcomes of PPG.Methods: We conducted a retrospective chart re...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of the American Academy of Dermatology Vol. 75; no. 5; pp. 931 - 940
Autores principales: Barbosa, Naiara S., Tolkachjov, Stanislav N., el-Azhary, Rokea A., Davis, Mark D.P., Camilleri, Michael J., McEvoy, Marian T., Bridges, Alina G., Wetter, David A.
Formato: Journal Article
Publicado: Elsevier B.V. Nov2016
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:Background: There are limited large case series of peristomal pyoderma gangrenosum (PPG), an uncommon cause of recalcitrant peristomal ulceration.Objective: We sought to further characterize the clinical features, causes, treatments, and outcomes of PPG.Methods: We conducted a retrospective chart review of patients with PPG seen at Mayo Clinic from January 1996 to July 2013.Results: A total of 44 patients had PPG (mean age, 46 years; 32 women [73%]); 41 (93%) had inflammatory bowel disease. Mean time to PPG onset after stoma surgery was 5.2 months (excluding 1 outlier). Systemic therapies included corticosteroids (66%), immunosuppressants (41%), biologics (36%), and a combination of systemic treatments (36%). Mean time to reach a complete response was 10.7 weeks. Stoma closure had the greatest complete response (4 of 4 patients, no recurrences). Recurrence after any treatment was documented in 23 of 38 (61%) patients. Stoma relocation/revision recurred in 10 of 15 (67%) patients. Remission occurred in 29 of 31 (94%) patients.Limitations: Small sample size and retrospective study design are limitations.Conclusion: PPG is strongly associated with inflammatory bowel disease, is predominant in women, and has a prolonged time to onset and high recurrence rate. Systemic corticosteroid or combination therapies and surgical closure can be effective treatments. Timely recognition and management are paramount to achieving early remission.